NUWE | Nuwellis, Inc. Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	2.0601 - 4.19
52 Week Range	1.0000 - 31.15
Beta	N/A
Implied Volatility	N/A
IV Rank	N/A
Day's Volume	99,725,627
Average Volume	671,595
Shares Outstanding	1,854,567
Market Cap	5,211,333
Sector	Healthcare
Industry	Medical - Devices
IPO Date	2012-02-16

Valuation
Profitability
Growth
Health
P/E Ratio	-0.02
Forward P/E Ratio	-4.52
EPS	-120.96
1YR Price Target	20.50
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	59
Country	USA
Website	NUWE

Nuwellis Inc is a medical device company. Its solutions include Aquadex Smartflow System and RenalSense Clarity RMS. The Aquadex Smartflow System removes excess fluid from patients suffering from fluid overload who have not responded to medical management, including diuretics. Clarity RMS is a kidney monitoring system that continuously measures urine output and flow, automatically displaying real-time data to the medical staff.

NUWE's peers: AEMD, BBLG, BJDX, BSGM, BVS, ECOR, HSDT, MYO, NAOV, NSPR, NURO, RSLS, TNON, RMED, INVO, THMO, SINT, TIVC, TLIS, HSCS, VERO, VVOS

*Chart delayed

Analyzing fundamentals for NUWE we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is bad and Health is frighteningly weak. For more detailed analysis please see NUWE Fundamentals page.

Watching at NUWE technicals we can see that long-term trend is bearish, while middle-term trend is bullish, as well as bullish short-term trend. More technicals details can be found on NUWE Technicals page.